Variant report
Variant | nsv1028223 |
---|---|
Chromosome Location | chr7:146226298-146267257 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:11)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:11 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:146233829..146237981-chr7:146239048..146242381,3 | K562 | blood: | |
2 | chr7:146259240..146261148-chr7:146262758..146264665,2 | K562 | blood: | |
3 | chr7:146259240..146261148-chr7:146262758..146264665,2 | K562 | blood: | |
4 | chr7:146253504..146256343-chr7:146261873..146263479,2 | K562 | blood: | |
5 | chr7:146235172..146238852-chr7:146239684..146242381,3 | K562 | blood: | |
6 | chr7:146253504..146256343-chr7:146261873..146263479,2 | K562 | blood: | |
7 | chr7:146233829..146237981-chr7:146239048..146242381,3 | K562 | blood: | |
8 | chr16:70557427..70557946-chr7:146244932..146245452,2 | Hela-S3 | cervix: | |
9 | chr7:146250194..146253829-chr7:146254649..146256608,3 | K562 | blood: | |
10 | chr7:146235172..146238852-chr7:146239684..146242381,3 | K562 | blood: | |
11 | chr7:146250194..146253829-chr7:146254649..146256608,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000103051 | chromatin interactions |
ENSG00000189091 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17170133 | chr7:146226298-146226299 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs149964698 | chr7:146226320-146226321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144106675 | chr7:146226335-146226336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs538603318 | chr7:146226361-146226362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558865936 | chr7:146226381-146226382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550415170 | chr7:146226447-146226448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575248843 | chr7:146226555-146226556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs17170134 | chr7:146226582-146226583 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs373447044 | chr7:146226615-146226616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs17585288 | chr7:146226654-146226655 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs182480838 | chr7:146226663-146226664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540806394 | chr7:146226709-146226710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73741733 | chr7:146226737-146226738 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs112819479 | chr7:146226780-146226781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546181188 | chr7:146226829-146226830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564827016 | chr7:146226830-146226831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530543818 | chr7:146226838-146226839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532573126 | chr7:146226846-146226847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550625916 | chr7:146226861-146226862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536397421 | chr7:146226882-146226883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2693410 | chr7:146226885-146226886 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs529859254 | chr7:146226918-146226919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546770873 | chr7:146226927-146226928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs57120378 | chr7:146226928-146226929 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs538886672 | chr7:146226986-146226987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558595048 | chr7:146226998-146226999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568882901 | chr7:146227011-146227012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186269283 | chr7:146227012-146227013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567154962 | chr7:146227026-146227027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs801944 | chr7:146227049-146227050 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs574582677 | chr7:146227050-146227051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143375032 | chr7:146227057-146227058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570526905 | chr7:146227058-146227059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs59533423 | chr7:146227089-146227090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191000471 | chr7:146227095-146227096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530310597 | chr7:146227111-146227112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577373372 | chr7:146227142-146227143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537658658 | chr7:146227192-146227193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs117915852 | chr7:146227337-146227338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201826752 | chr7:146227360-146227361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563156506 | chr7:146227414-146227415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368321310 | chr7:146227464-146227465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576845022 | chr7:146227481-146227482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35327543 | chr7:146227498-146227499 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs56667036 | chr7:146227503-146227504 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs543318708 | chr7:146227508-146227509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546389135 | chr7:146227515-146227516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373031251 | chr7:146227516-146227517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372240130 | chr7:146227566-146227567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560261389 | chr7:146227573-146227574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pancreatitis | 21956041 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Epilepsy | 20502679 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Medulloblastoma | 21163964 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:146225600-146226800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr7:146225800-146226400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
3 | chr7:146226800-146229400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr7:146229400-146229800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr7:146231400-146242000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr7:146235400-146235600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr7:146235600-146236600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr7:146236200-146237800 | Enhancers | Fetal Kidney | kidney |
9 | chr7:146236600-146237000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr7:146238800-146239400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr7:146239000-146239400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr7:146239200-146239400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr7:146260000-146260400 | Enhancers | Fetal Kidney | kidney |
14 | chr7:146260200-146260800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
15 | chr7:146262800-146263200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr7:146262800-146263200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr7:146262800-146263200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr7:146262800-146263200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr7:146262800-146263400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr7:146262800-146263400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr7:146263000-146263400 | Enhancers | Ovary | ovary |